关注
Sehmus Ertop
Sehmus Ertop
Bülent Ecevit Üniversitesi Tıp Fakültesi Hematoloji Profesörü
在 beun.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pesg PNH diagnosis, follow-up and treatment guidelines
F Sahin, OM Akay, M Ayer, MS Dal, S Ertop, O Ilhan, V Karakus, ...
American journal of blood research 6 (2), 19, 2016
552016
Cholesterol levels in patients with chronic lymphocytic leukemia
I Yavasoglu, G Sargin, F Yilmaz, S Altındag, G Akgun, A Tombak, B Toka, ...
Journal of the National Medical Association 109 (1), 23-27, 2017
312017
Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer
H Engin, Y Üstündağ, İÖ Tekin, A Gökmen, Ş Ertop, SU İlikhan
European cytokine network 23 (2), 68-71, 2012
252012
A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: a real-life experience
RKİTT Eltrombopagın, Eİ Çok, GY Deneyimi
Turk J Hematol 36, 230-237, 2019
162019
İmmünoloji, Saray Medikal Yayıncılık
E Müftüoğlu, Z Bolaman, O Bilgir, Ş Ertop
İzmir, 1993
51993
The predictive value of factor V Leiden, prothrombin G20210A and MTHFR C677T Gene mutations on the location of venous thromboembolism
M Bilici, İ Öz, S İlikhan, M Arslaner, E Kahraman, B Kılavuz, Z Özdamar, ...
Dicle Tıp Dergisi 42 (4), 467-471, 2015
42015
The clinical efficacy of epoetin alfa and darbepoetin alfa in patients with low-risk or intermediate-1-risk myelodysplastic syndrome: retrospective multi-center real-life study
MA Ak, B Sahip, A Geduk, MA Ucar, H Kale, T Hacibekiroglu, MG Polat, ...
Indian Journal of Hematology and Blood Transfusion 38 (2), 299-308, 2022
32022
Abnormalities of peripheral blood parameters in hospitalized patients with COVID-19: a temporal change analysis in relation to survival
MA Ak, B Sahip, G Çelebi, E Horuz, Ş Ertop
Batı Karadeniz Tıp Dergisi 5 (3), 391-400, 2021
32021
Red cell distribution width has a predictable value for differentiation of provoked and unprovoked venous thromboembolism
S Ertop, M Bilici, H Engin, C Buyukuysal, M Arslaner, B Toka, IO Tekin
Indian Journal of Hematology and Blood Transfusion 32, 481-487, 2016
32016
Efficacy and safety of ibrutinib therapy in patients with chronic lymphocytic leukemia: retrospective analysis of real-life data
A Tombak, FP Tanrıkulu, SS Durusoy, HD Dinçyürek, E Kaya, EG Ümit, ...
Turkish Journal of Hematology 38 (4), 273, 2021
22021
Hematolojik Tanıda Anamnez ve Fizik Muayene
B Sahip, M ASLANER, Ş ERTOP
Tanısal Hematoloji, 1-5, 2020
22020
Changes in MPVand PDW Values in Patients Receiving Chemotherapy for Colon and Gastric Cancers
B Toka, M Arslaner, C Bilir, H Engin, Ş Ertop
Journal of Human Rhythm 3 (3), 157-163, 2017
22017
Venöz tromboemboli yerleşim yeri üzerine Faktör V Leiden, Protrombin G20210A ve MTHFR C677T Gen mutasyonlarının belirleyici rolü
M Bilici, İİ Öz, SU İlikhan, M Arslaner, E Kahraman, B Kılavuz, Z Özdamar, ...
Ertop3Dicle Tıp Dergisi, 4, 2015
22015
The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients
G Öztürk, MA Ak, S Ertop
Dicle Tıp Dergisi 48 (4), 754-760, 2021
12021
Original versus generic lenalidomide in patients with relapsed/refractory multiple myeloma: comparison of efficacy and adverse events
AZ Bolaman, A Turgutkaya, B Sahip, C Selim, HE Küçükdiler, Ş Ertop, ...
Turkish Journal of Hematology 38 (1), 41, 2021
12021
Efficacy and safety of ibrutinib use in patients with chronic lymphocytic leukemia in real world experiences: results of a prospective multicenter study
A Tombak, FP Tanrikulu, SS Durusoy, E Gurkan, E Kaya, EG Umit, ...
Blood 134, 5476, 2019
12019
Derin Ven Trombozu Gelişen Kanser Hastalarında Embolizm ve Kan Grupları Arasındaki İlişki.
C Bilir, H Engin, YB Temi, MG Haytaoğlu, S Ertop
Sakarya Tıp Dergisi 3 (2), 72-75, 2013
12013
TREATMENT OF BLASTIC PHASE CHRONIC MYELOGENOUS LEUKEMIA WITH MEGA-DOSE METHYL-PREDNISOLONE
Z Bolaman, O Bilgir, S Ertop, N Yenice, E YILMAZ, E MUFTUOGLU
JOURNAL OF CHEMOTHERAPY 5, 670-671, 1993
11993
A CASE OF RECURRENT DIFFUSE LARGE B CELL NONHODGKIN LYMPHOMA WITH SKIN INVOLVEMENT
MA Ak, BS Yesiralioğlu, H Ayağ, PE Doğan, Ş Ertop
Hematology, Transfusion and Cell Therapy 46, 17-18, 2024
2024
MAINTENANCE LOW-DOSE CORTICOSTEROID THERAPY IN PATIENTS WITH CHRONIC ITP: SINGLE CENTER RESULTS
BS Yesiralioğlu, H Ayağ, MA Ak, Ş Ertop
Hematology, Transfusion and Cell Therapy 46, 5, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20